Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Oct;94(4):1397–1403. doi: 10.1172/JCI117475

Augmented agonist-induced Ca(2+)-sensitization of coronary artery contraction in genetically hypertensive rats. Evidence for altered signal transduction in the coronary smooth muscle cells.

S Satoh 1, R Kreutz 1, C Wilm 1, D Ganten 1, G Pfitzer 1
PMCID: PMC295265  PMID: 7929815

Abstract

The Ca2+ responsiveness of vascular smooth muscle myofilaments is not unique: it is increased during neuro-humoral activation and decreased during beta-adrenergic stimulation. In this study we tested whether an augmented Ca2+ responsiveness of smooth muscle myofilaments may contribute to the increased coronary tone observed in hypertension using beta-escin-permeabilized coronary arteries from 3-mo-old stroke-prone spontaneously hypertensive rats (SHRSP) and their age matched normotensive reference strain (WKY rats). In intact coronary arteries, the response to 5-hydroxytryptamine (5-HT) but not to KCl was larger in SHRSP than in WKY rats. In beta-escin permeabilized coronary arteries in which the receptor effector coupling is still intact, 5-HT enhanced force at constant submaximal (Ca2+) (pCa 6.38) to a greater extent in SHRSP. The Ca2+ sensitizing effect of 5-HT was mimicked by GTP gamma S (0.01-10 microM); again this effect was larger in SHRSP. In the absence of 5-HT or GTP gamma S the Ca2+ force relation was similar in both groups. Forskolin induced relaxation at constant submaximal (Ca2+). This desensitizing effect was smaller in SHRSP than in WKY rats. In conclusion, this study shows that intracellular signalling pathways involved in modulating the Ca2+ responsiveness of coronary smooth muscle myofilaments are altered in the genetically hypertensive animals favoring a hypercontractile state in the coronary circulation.

Full text

PDF
1397

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asano M., Masuzawa K., Matsuda T., Asano T. Reduced function of the stimulatory GTP-binding protein in beta adrenoceptor-adenylate cyclase system of femoral arteries isolated from spontaneously hypertensive rats. J Pharmacol Exp Ther. 1988 Aug;246(2):709–718. [PubMed] [Google Scholar]
  2. Bazan E., Campbell A. K., Rapoport R. M. Protein kinase C activity in blood vessels from normotensive and spontaneously hypertensive rats. Eur J Pharmacol. 1992 Nov 2;227(3):343–348. doi: 10.1016/0922-4106(92)90014-m. [DOI] [PubMed] [Google Scholar]
  3. Boels P. J., Claes V. A., Brutsaert D. L. Mechanics of K(+)-induced isotonic and isometric contractions in isolated canine coronary microarteries. Am J Physiol. 1990 Mar;258(3 Pt 1):C512–C523. doi: 10.1152/ajpcell.1990.258.3.C512. [DOI] [PubMed] [Google Scholar]
  4. Boels P. J., Troschka M., Rüegg J. C., Pfitzer G. Higher Ca2+ sensitivity of triton-skinned guinea pig mesenteric microarteries as compared with large arteries. Circ Res. 1991 Oct;69(4):989–996. doi: 10.1161/01.res.69.4.989. [DOI] [PubMed] [Google Scholar]
  5. Bohr D. F., Webb R. C. Vascular smooth muscle membrane in hypertension. Annu Rev Pharmacol Toxicol. 1988;28:389–409. doi: 10.1146/annurev.pa.28.040188.002133. [DOI] [PubMed] [Google Scholar]
  6. Bradley A. B., Morgan K. G. Alterations in cytoplasmic calcium sensitivity during porcine coronary artery contractions as detected by aequorin. J Physiol. 1987 Apr;385:437–448. doi: 10.1113/jphysiol.1987.sp016500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Childs T. J., Watson M. H., Sanghera J. S., Campbell D. L., Pelech S. L., Mak A. S. Phosphorylation of smooth muscle caldesmon by mitogen-activated protein (MAP) kinase and expression of MAP kinase in differentiated smooth muscle cells. J Biol Chem. 1992 Nov 15;267(32):22853–22859. [PubMed] [Google Scholar]
  8. Clozel J. P., Kuhn H., Hefti F. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J Hypertens. 1989 Apr;7(4):267–275. [PubMed] [Google Scholar]
  9. Cocks T. M., Angus J. A. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 1983 Oct 13;305(5935):627–630. doi: 10.1038/305627a0. [DOI] [PubMed] [Google Scholar]
  10. Collins E. M., Walsh M. P., Morgan K. G. Contraction of single vascular smooth muscle cells by phenylephrine at constant [Ca2+]i. Am J Physiol. 1992 Mar;262(3 Pt 2):H754–H762. doi: 10.1152/ajpheart.1992.262.3.H754. [DOI] [PubMed] [Google Scholar]
  11. DeFeo T. T., Morgan K. G. Calcium-force relationships as detected with aequorin in two different vascular smooth muscles of the ferret. J Physiol. 1985 Dec;369:269–282. doi: 10.1113/jphysiol.1985.sp015900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Eckstein F., Cassel D., Levkovitz H., Lowe M., Selinger Z. Guanosine 5'-O-(2-thiodiphosphate). An inhibitor of adenylate cyclase stimulation by guanine nucleotides and fluoride ions. J Biol Chem. 1979 Oct 10;254(19):9829–9834. [PubMed] [Google Scholar]
  13. Egashira K., Inou T., Hirooka Y., Yamada A., Maruoka Y., Kai H., Sugimachi M., Suzuki S., Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest. 1993 Jan;91(1):29–37. doi: 10.1172/JCI116183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. FURUYAMA M. Histometrical investigations of arteries in reference to arterial hypertension. Tohoku J Exp Med. 1962 May 25;76:388–414. doi: 10.1620/tjem.76.388. [DOI] [PubMed] [Google Scholar]
  15. Frohlich E. D., Apstein C., Chobanian A. V., Devereux R. B., Dustan H. P., Dzau V., Fauad-Tarazi F., Horan M. J., Marcus M., Massie B. The heart in hypertension. N Engl J Med. 1992 Oct 1;327(14):998–1008. doi: 10.1056/NEJM199210013271406. [DOI] [PubMed] [Google Scholar]
  16. Fujiwara T., Itoh T., Kubota Y., Kuriyama H. Effects of guanosine nucleotides on skinned smooth muscle tissue of the rabbit mesenteric artery. J Physiol. 1989 Jan;408:535–547. doi: 10.1113/jphysiol.1989.sp017474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gong M. C., Fuglsang A., Alessi D., Kobayashi S., Cohen P., Somlyo A. V., Somlyo A. P. Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium. J Biol Chem. 1992 Oct 25;267(30):21492–21498. [PubMed] [Google Scholar]
  18. Hebert P. R., Fiebach N. H., Eberlein K. A., Taylor J. O., Hennekens C. H. The community-based randomized trials of pharmacologic treatment of mild-to-moderate hypertension. Am J Epidemiol. 1988 Mar;127(3):581–590. doi: 10.1093/oxfordjournals.aje.a114833. [DOI] [PubMed] [Google Scholar]
  19. Himpens B., Kitazawa T., Somlyo A. P. Agonist-dependent modulation of Ca2+ sensitivity in rabbit pulmonary artery smooth muscle. Pflugers Arch. 1990 Sep;417(1):21–28. doi: 10.1007/BF00370764. [DOI] [PubMed] [Google Scholar]
  20. Hirata K., Kikuchi A., Sasaki T., Kuroda S., Kaibuchi K., Matsuura Y., Seki H., Saida K., Takai Y. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem. 1992 May 5;267(13):8719–8722. [PubMed] [Google Scholar]
  21. Högestätt E. D., Andersson K. E., Edvinsson L. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand. 1983 Jan;117(1):49–61. doi: 10.1111/j.1748-1716.1983.tb07178.x. [DOI] [PubMed] [Google Scholar]
  22. Katsuyama H., Wang C. L., Morgan K. G. Regulation of vascular smooth muscle tone by caldesmon. J Biol Chem. 1992 Jul 25;267(21):14555–14558. [PubMed] [Google Scholar]
  23. Khalil R. A., Lajoie C., Resnick M. S., Morgan K. G. Ca(2+)-independent isoforms of protein kinase C differentially translocate in smooth muscle. Am J Physiol. 1992 Sep;263(3 Pt 1):C714–C719. doi: 10.1152/ajpcell.1992.263.3.C714. [DOI] [PubMed] [Google Scholar]
  24. Kitazawa T., Masuo M., Somlyo A. P. G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9307–9310. doi: 10.1073/pnas.88.20.9307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kobayashi S., Gong M. C., Somlyo A. V., Somlyo A. P. Ca2+ channel blockers distinguish between G protein-coupled pharmacomechanical Ca2+ release and Ca2+ sensitization. Am J Physiol. 1991 Feb;260(2 Pt 1):C364–C370. doi: 10.1152/ajpcell.1991.260.2.C364. [DOI] [PubMed] [Google Scholar]
  26. Kobayashi S., Kitazawa T., Somlyo A. V., Somlyo A. P. Cytosolic heparin inhibits muscarinic and alpha-adrenergic Ca2+ release in smooth muscle. Physiological role of inositol 1,4,5-trisphosphate in pharmacomechanical coupling. J Biol Chem. 1989 Oct 25;264(30):17997–18004. [PubMed] [Google Scholar]
  27. Kubota Y., Nomura M., Kamm K. E., Mumby M. C., Stull J. T. GTP gamma S-dependent regulation of smooth muscle contractile elements. Am J Physiol. 1992 Feb;262(2 Pt 1):C405–C410. doi: 10.1152/ajpcell.1992.262.2.C405. [DOI] [PubMed] [Google Scholar]
  28. Kwan C. Y. Dysfunction of calcium handling by smooth muscle in hypertension. Can J Physiol Pharmacol. 1985 Apr;63(4):366–374. doi: 10.1139/y85-066. [DOI] [PubMed] [Google Scholar]
  29. Lee R. M., Garfield R. E., Forrest J. B., Daniel E. E. Morphometric study of structural changes in the mesenteric blood vessels of spontaneously hypertensive rats. Blood Vessels. 1983;20(2):57–71. doi: 10.1159/000158460. [DOI] [PubMed] [Google Scholar]
  30. Leevers S. J., Marshall C. J. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 1992 Feb;11(2):569–574. doi: 10.1002/j.1460-2075.1992.tb05088.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lindpaintner K., Kreutz R., Ganten D. Genetic variation in hypertensive and 'control' strains. What are we controlling for anyway? Hypertension. 1992 May;19(5):428–430. doi: 10.1161/01.hyp.19.5.428. [DOI] [PubMed] [Google Scholar]
  32. MacKay M. J., Cheung D. W. Increased reactivity in the mesenteric artery of spontaneously hypertensive rats to phorbol ester. Biochem Biophys Res Commun. 1987 Jun 30;145(3):1105–1111. doi: 10.1016/0006-291x(87)91551-8. [DOI] [PubMed] [Google Scholar]
  33. McLellan A. R., Milligan G., Houslay M. D., Connell J. M. G-proteins in experimental hypertension: a study of spontaneously hypertensive rat myocardial and renal cortical plasma membranes. J Hypertens. 1993 Apr;11(4):365–372. doi: 10.1097/00004872-199304000-00006. [DOI] [PubMed] [Google Scholar]
  34. McMahon E. G., Paul R. J. Calcium sensitivity of isometric force in intact and chemically skinned aortas during the development of aldosterone-salt hypertension in the rat. Circ Res. 1985 Mar;56(3):427–435. doi: 10.1161/01.res.56.3.427. [DOI] [PubMed] [Google Scholar]
  35. Morgan J. P., Morgan K. G. Alteration of cytoplasmic ionized calcium levels in smooth muscle by vasodilators in the ferret. J Physiol. 1984 Dec;357:539–551. doi: 10.1113/jphysiol.1984.sp015516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mrwa U., Güth K., Haist C., Troschka M., Herrmann R., Wojciechowski R., Gagelmann M. Calcium-requirement for activation of skinned vascular smooth muscle from spontaneously hypertensive (SHRSP) and normotensive control rats. Life Sci. 1986 Jan 13;38(2):191–196. doi: 10.1016/0024-3205(86)90011-1. [DOI] [PubMed] [Google Scholar]
  37. Mulvany M. J., Nyborg N. An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats. Br J Pharmacol. 1980;71(2):585–596. doi: 10.1111/j.1476-5381.1980.tb10977.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mulvany M. J. Role of vascular structure in blood pressure development of the spontaneously hypertensive rat. J Hypertens Suppl. 1986 Oct;4(3):S61–S63. [PubMed] [Google Scholar]
  39. Nishimura J., Kolber M., van Breemen C. Norepinephrine and GTP-gamma-S increase myofilament Ca2+ sensitivity in alpha-toxin permeabilized arterial smooth muscle. Biochem Biophys Res Commun. 1988 Dec 15;157(2):677–683. doi: 10.1016/s0006-291x(88)80303-6. [DOI] [PubMed] [Google Scholar]
  40. Nyborg N. C., Mikkelsen E. O. 5-Hydroxytryptamine does not release endothelium-derived relaxing factor in rat isolated coronary arteries. Eur J Pharmacol. 1990 Sep 21;186(2-3):295–300. doi: 10.1016/0014-2999(90)90447-e. [DOI] [PubMed] [Google Scholar]
  41. Panza J. A., Quyyumi A. A., Brush J. E., Jr, Epstein S. E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990 Jul 5;323(1):22–27. doi: 10.1056/NEJM199007053230105. [DOI] [PubMed] [Google Scholar]
  42. Pearson P. J., Vanhoutte P. M. Vasodilator and vasoconstrictor substances produced by the endothelium. Rev Physiol Biochem Pharmacol. 1993;122:1–67. doi: 10.1007/BFb0035273. [DOI] [PubMed] [Google Scholar]
  43. Pfitzer G., Boels P. J. Differential skinning of smooth muscle: a new approach to excitation-contraction coupling. Blood Vessels. 1991;28(1-3):262–267. doi: 10.1159/000158872. [DOI] [PubMed] [Google Scholar]
  44. Pfitzer G., Rüegg J. C., Zimmer M., Hofmann F. Relaxation of skinned coronary arteries depends on the relative concentrations of Ca2+, calmodulin and active cAMP-dependent protein kinase. Pflugers Arch. 1985 Sep;405(1):70–76. doi: 10.1007/BF00591100. [DOI] [PubMed] [Google Scholar]
  45. Pfitzer G., Zeugner C., Troschka M., Chalovich J. M. Caldesmon and a 20-kDa actin-binding fragment of caldesmon inhibit tension development in skinned gizzard muscle fiber bundles. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5904–5908. doi: 10.1073/pnas.90.13.5904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Price B. D., Morris J. D., Marshall C. J., Hall A. Stimulation of phosphatidylcholine hydrolysis, diacylglycerol release, and arachidonic acid production by oncogenic ras is a consequence of protein kinase C activation. J Biol Chem. 1989 Oct 5;264(28):16638–16643. [PubMed] [Google Scholar]
  47. Satoh S., Rensland H., Pfitzer G. Ras proteins increase Ca(2+)-responsiveness of smooth muscle contraction. FEBS Lett. 1993 Jun 14;324(2):211–215. doi: 10.1016/0014-5793(93)81395-g. [DOI] [PubMed] [Google Scholar]
  48. Satoh S., Tomoike H., Mitsuoka W., Egashira S., Tagawa H., Kuga T., Nakamura M. Smooth muscles from spastic coronary artery segments show hypercontractility to histamine. Am J Physiol. 1990 Jul;259(1 Pt 2):H9–13. doi: 10.1152/ajpheart.1990.259.1.H9. [DOI] [PubMed] [Google Scholar]
  49. Silver P. J., Michalak R. J., Kocmund S. M. Role of cyclic AMP protein kinase in decreased arterial cyclic AMP responsiveness in hypertension. J Pharmacol Exp Ther. 1985 Mar;232(3):595–601. [PubMed] [Google Scholar]
  50. Triggle C. R., Laher I. A review of changes in vascular smooth muscle functions in hypertension: isolated tissue versus in vivo studies. Can J Physiol Pharmacol. 1985 Apr;63(4):355–365. doi: 10.1139/y85-065. [DOI] [PubMed] [Google Scholar]
  51. Vanhoutte P. M. 5-hydroxytryptamine and vascular disease. Fed Proc. 1983 Feb;42(2):233–237. [PubMed] [Google Scholar]
  52. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980 Jul;47(1):1–9. doi: 10.1161/01.res.47.1.1. [DOI] [PubMed] [Google Scholar]
  53. del Cerro M., Cogen J., del Cerro C. Stevenel's Blue, an excellent stain for optical microscopical study of plastic embedded tissues. Microsc Acta. 1980 May;83(2):117–121. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES